Five-Year Visual Function and Refractive Outcomes After Congenital Cataract Surgery
- Conditions
- Congenital CataractPediatric Cataract
- Registration Number
- NCT07070037
- Lead Sponsor
- Jin Yang
- Brief Summary
This prospective multicenter observational study aims to evaluate the 5-year visual function and refractive outcomes in children undergoing surgery for congenital cataract. Key outcomes include best-corrected visual acuity, stereopsis, refractive error, and axial length growth. The study will help identify long-term trends and prognostic indicators after early cataract intervention in pediatric patients.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 400
- Diagnosis of congenital cataract
- Underwent cataract extraction before 1 year of age
- Available for regular follow-up for at least 5 years postoperatively
- Written informed consent from legal guardian
- Acquired cataract or traumatic origin
- Associated ocular malformations (e.g., microphthalmia, coloboma)
- Systemic syndromes affecting vision (e.g., Down syndrome)
- History of secondary surgery affecting visual outcome
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Visual Acuity Participants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively. UDVA and BCVA will be assessed using age-appropriate optotypes (e.g., Snellen chart, ETDRS chart, or Lea symbols) and recorded in logMAR units at the last available follow-up, with a minimum duration of 5 years postoperatively.
axial length Participants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively. AL
Refractive Error Participants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively. Refractive Error
- Secondary Outcome Measures
Name Time Method IOP Participants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively. intraocular pressure
Corneal Curvature (K1 and K2) by Pentacam Participants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively. Flat (K1) and steep (K2) corneal curvature values will be measured using Pentacam and recorded in diopters (D).
Stereopsis Participants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively. Stereopsis will be assessed using age-appropriate tools (e.g., Randot Preschool or Titmus Fly Test) and reported in seconds of arc. Loss of stereopsis is defined as \>3000 arcsec.
white to white Participants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively. WTW (mm)
anterior chamber depth Participants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively. ACD(mm)
Complications Participants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively. Any postoperative complications following congenital cataract surgery, including glaucoma, anterior capsular opacification (ACO), etc.
Central Corneal Thickness (CCT) Participants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively. Corneal pachymetry will be measured with Pentacam at the central point and reported in microns (µm).
Corneal Astigmatism Magnitude Participants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively. Corneal astigmatism will be calculated from the difference between steep and flat meridians (K2-K1) using Pentacam data, and reported in diopters.
Binocular Fusion Assessment Participants will be followed at 1 week, 1 month, 3 months, 6 months, and annually from 1 to 5 years postoperatively. Binocular fusion will be evaluated using the Worth 4-Dot test under near and distance conditions. Results will be categorized as "fusion", "suppression", or "alternation".
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (1)
Eye and ENT hospital of Fudan University
🇨🇳Shanghai, Shanghai, China
Eye and ENT hospital of Fudan University🇨🇳Shanghai, Shanghai, ChinaXuanqiao LinContact150889206681532483480@qq.com